MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung

Desheng Wei1

  • 1Department of Thoracic Surgery, Shaoxing People's Hospital, Shaoxing, China. ghuasd1990@163.com.

Abstract

Insights

MicroRNA-486-5p (miR-486-5p) is downregulated in lung adenocarcinoma (LUAD). Restoring miR-486-5p suppresses LUAD cell proliferation, apoptosis, migration, and invasion by targeting SAPCD2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-486-5p (miR-486-5p) expression is significantly reduced in lung adenocarcinoma (LUAD).
  • The precise role and biological functions of miR-486-5p in LUAD remain largely unexplored.

Purpose of the Study:

  • To investigate the biofunctions of miR-486-5p in lung adenocarcinoma.
  • To elucidate the molecular mechanisms underlying miR-486-5p's role in LUAD progression.

Main Methods:

  • Differential gene expression analysis using The Cancer Genome Atlas (TCGA)-LUAD dataset.
  • Quantitative real-time PCR (qRT-PCR) and Western blot to analyze miR-486-5p and SAPCD2 expression.
  • In vitro functional assays including MTT, flow cytometry, Transwell assays, and dual-luciferase reporter assays to assess cell proliferation, apoptosis, migration, invasion, and miRNA-mRNA targeting.

Main Results:

  • MiR-486-5p expression was found to be significantly downregulated in LUAD tissues and cell lines.
  • Overexpression of miR-486-5p inhibited proliferation, anti-apoptotic tendencies, migration, and invasion of LUAD cells.
  • SAPCD2 was identified as a direct target of miR-486-5p, and its forced expression could counteract the suppressive effects of miR-486-5p on LUAD cell malignant phenotypes.

Conclusions:

  • MiR-486-5p acts as a tumor suppressor in LUAD by inhibiting malignant cell progression through targeting SAPCD2.
  • MiR-486-5p and SAPCD2 represent potential therapeutic targets for lung adenocarcinoma treatment.